Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
  2. Martin, Pat; Naranbhai, Vivek; Shea, Patrick R.; Qi, Ying; Ramsuran, Veron; Vince, Nicolas; Gao, Xiaojiang; Thomas, Rasmi; Brumme, Zabrina L.; Carlson, Jonathan M.; Wolinsky, Steven M.; Goedert, James J.; Walker, Bruce D.; Segal, Florencia P.; Deeks, Steven G.; Haas, David W.; Migueles, Stephen A.; Connors, Mark; Michael, Nelson; Fellay, Jacques; Gostick, Emma; Llewellyn-Lacey, Sian; Price, David A.; Lafont, Bernard A.; Pymm, Phillip; Saunders, Philippa M.; Widjaja, Jacqueline; Wong, Shu Cheng; Vivian, Julian P.; Rossjohn, Jamie; Brooks, Andrew G.; Carrington, Mary
  3. Journal of Clinical Investigation. 2018, May 01; 128(5): 1903-1912.
  1. 2.   Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
  2. Chen, H. Y.; Hayashi, G.; Lai, O. Y.; Dilthey, A.; Kuebler, P. J.; Wong, T. V.; Martin, M. P.; Vina, M. A. F.; McVean, G.; Wabl, M.; Leslie, K. S.; Maurer, T.; Martin, J. N.; Deeks, S. G.; Carrington, M.; Bowcock, A. M.; Nixon, D. F.; Liao, W.
  3. Plos Genetics. 2012, Feb; 8(2):
  1. 3.   Ex vivo functional responses to HLA-G differ between blood and decidual NK cells
  2. Apps, R.; Sharkey, A.; Gardner, L.; Male, V.; Kennedy, P.; Masters, L.; Farrell, L.; Jones, D.; Thomas, R.; Moffett, A.
  3. Molecular Human Reproduction. 2011, Sep; 17(9): 577-586.
  1. 4.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 5.   Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
  2. Hiby, S. E.; Apps, R.; Sharkey, A. M.; Farrell, L. E.; Gardner, L.; Mulder, A.; Claas, F. H.; Walker, J. J.; Redman, C. C.; Morgan, L.; Tower, C.; Regan, L.; Moore, G. E.; Carrington, M.; Moffett, A.
  3. Journal of Clinical Investigation. 2010, Nov; 120(11): 4102-4110.
  1. 6.   Inhibitory TCR Coreceptor PD-1 Is a Sensitive Indicator of Low-Level Replication of SIV and HIV-1
  2. Salisch, N. C.; Kaufmann, D. E.; Awad, A. S.; Reeves, R. K.; Tighe, D. P.; Li, Y.; Piatak, M.; Lifson, J. D.; Evans, D. T.; Pereyra, F.; Freeman, G. J.; Johnson, R. P.
  3. Journal of Immunology. 2010, Jan; 184(1): 476-487.
  1. 7.   HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses
  2. Huang, J. H.; Goedert, J. J.; Sundberg, E. J.; Cung, T. D. H.; Burke, P. S.; Martin, M. P.; Preiss, L.; Lifson, J.; Lichterfeld, M.; Carrington, M.; Yu, X. G.
  3. Journal of Experimental Medicine. 2009, Dec; 206(13): 2959-2966.
  1. 8.   A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates
  2. Averdam, A.; Petersen, B.; Rosner, C.; Neff, J.; Roos, C.; Eberle, M.; Aujard, F.; Munich, C.; Schempp, W.; Carrington, M.; Shiina, T.; Inoko, H.; Knaust, F.; Coggill, P.; Sehra, H.; Beck, S.; Abi-Rached, L.; Reinhardt, R.; Walter, L.
  3. Plos Genetics. 2009 5(10):
  1. 9.   HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
  2. Thomas, R.; Apps, R.; Qi, Y.; Gao, X. J.; Male, V.; O'hUigin, C.; O'Connor, G.; Ge, D. L.; Fellay, J.; Martin, J. N.; Margolick, J.; Goedert, J. J.; Buchbinder, S.; Kirk, G. D.; Martin, M. P.; Telenti, A.; Deeks, S. G.; Walker, B. D.; Goldstein, D.
  3. Nature Genetics. 2009 41(12): 1290-U46.
  1. 10.   Contribution of CD8(+) T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in simian immunodeficiency virus-infected rhesus monkeys
  2. Kim, E. Y.; Veazey, R. S.; Zahn, R.; McEvers, K. J.; Baumeister, S.; Foster, G. J.; Rett, M. D.; Newberg, M. H.; Kuroda, M. J.; Rieber, E. P.; Piatak, M.; Lifson, J. D.; Letvin, N. L.; Wolinsky, S. M.; Schmitz, J. E.
  3. Journal of Virology. 2008 82(11): 5631-5635.
  1. 11.   TAP-1 indirectly regulates CD4(+) T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production
  2. Goldszmid, R. S.; Bafica, A.; Jankovic, D.; Feng, C. G.; Caspar, P.; Winkler-Pickett, R.; Trinchieri, G.; Sher, A.
  3. Journal of Experimental Medicine. 2007, Oct; 204(11): 2591-2602.
  1. 12.   Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level
  2. Andersen, H.; Rossio, J. L.; Coalter, V.; Poore, B.; Martin, M. P.; Carrington, M.; Lifson, J. D.
  3. Cellular Immunology. 2004, SEP-OCT; 231(1-2): 85-95.
  1. 13.   Human genes that limit AIDS
  2. O'Brien, S. J.; Nelson, G. W.
  3. Nature Genetics. 2004 36(6): 565-574.
  1. 14.   NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade
  2. Koh, C. Y.; Ortaldo, J. R.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Blood. 2003 102(12): 4067-4075.
  1. 15.   A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV- speeific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 Rhesus macaques
  2. Malkevitch, N.; Patterson, L. J.; Aldrich, K.; Richardson, E.; Alvord, W. G.; Robert-Guroff, M.
  3. Journal of Immunology. 2003 170(8): 4281-4289.
  1. 16.   The ever-expanding Ly49 gene family: repertoire and signaling
  2. Anderson, S. K.; Ortaldo, J. R.; McVicar, D. W.
  3. Immunological Reviews. 2001 181: 79-89.
  1. 17.   Interaction of Ly-49D(+) NK cells with H-2D(d) target cells leads to Dap-12 phosphorylation and IFN-gamma secretion
  2. Mason, L. H.; Willette-Brown, J.; Mason, A. T.; McVicar, D.; Ortaldo, J. R.
  3. Journal of Immunology. 2000 164(2): 603-611.
  1. 18.   Functional association of Fc epsilon RI gamma with Arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages
  2. Taylor, L. S.; McVicar, D. W.
  3. Blood. 1999 94(5): 1790-1796.
  1. 19.   HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
  2. Carrington, M.; Nelson, G. W.; Martin, M. P.; Kissner, T.; Vlahov, D.; Goedert, J. J.; Kaslow, R.; Buchbinder, S.; Hoots, K.; O'Brien, S. J.
  3. Science. 1999 283(5408): 1748-1752.
  1. 20.   Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors
  2. Ortaldo, J. R.; Winkler-Pickett, R.; Willette-Brown, J.; Wange, R. L.; Anderson, S. K.; Palumbo, G. J.; Mason, L. H.; McVicar, D. W.
  3. Journal of Immunology. 1999 163(10): 5269-5277.
  1. 21.   The presence and absence of histocompatibility antigens in HIV type 1 produced by autologous blood-derived macrophages and peripheral blood lymphoblasts
  2. Tsai, W. P.; Kung, H. F.; Nara, P. L.
  3. Aids Research and Human Retroviruses. 1999 15(1): 33-41.
  1. 22.   DAP12-mediated signal transduction in a natural killer cells - A dominant role for the Syk protein-tyrosine kinase
  2. McVicar, D. W.; Taylor, L. S.; Gosselin, P.; Willette-Brown, J.; Mikhael, A. I.; Geahlen, R. L.; Nakamura, M. C.; Linnemeyer, P.; Seaman, W. E.; Anderson, S. K.; Ortaldo, J. R.; Mason, L. H.
  3. Journal of Biological Chemistry. 1998 273(49): 32934-32942.
  1. 23.   Frequency of Hla Allele-Specific Peptide Motifs in Hiv-1 Proteins Correlates With the Alleles Association With Relative Rates of Disease Progression After Hiv-1 Infection
  2. Nelson, G. W.; Kaslow, R.; Mann, D. L.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1997 94(18): 9802-9807.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel